Latest Market Growth News

CleanSpace Holdings posted a robust 26% revenue increase in FY25, turning the corner to positive EBITDA and cash flow in the second half, driven by strong industrial market demand and operational efficiencies.

Centrepoint Alliance has reported a robust FY25 financial performance, surpassing earnings guidance with a 16% rise in EBITDA and a 30% jump in pre-tax profits. The company also declared a 1.75 cent final dividend and advanced its technology and advisory services.

Australian Clinical Labs delivered solid FY25 financial results with revenue up 6.4% and EBIT rising 8.7%, underpinned by operational efficiencies and strategic innovation. The company’s FY26 guidance signals continued growth amid evolving market conditions and government fee pressures.

Australian Clinical Labs reported robust FY25 financial results with revenue and earnings growth, alongside a strong dividend payout and positive outlook for FY26.

EVT Limited reported solid full-year FY25 results with revenue and profit growth, driven by record hotel performance and a recovering entertainment division. The group signals confidence with a strong dividend and optimistic FY26 outlook.

X2M Connect has successfully completed an oversubscribed capital raise, securing $5.4 million to strengthen its balance sheet and accelerate growth across Asia and the Middle East.

LTR Pharma has announced that its erectile dysfunction treatment SPONTAN now boasts an 18-month shelf life, surpassing commercial standards and paving the way for international market growth.

Zip Co Limited reported a robust FY25 with revenue up 23.5% to $1.07 billion and cash earnings soaring 147%, driven by strong US market expansion and operational efficiencies.

hipages Group reported a 10% revenue increase for FY25, driven by strong SaaS platform adoption and operational efficiencies, despite a 33% net profit decline influenced by prior year gains.

RooLife Group Ltd (ASX, RLG) has launched its proprietary RLG Coffee brand in China, tapping into a rapidly expanding market with early sales exceeding $110,000 in the first month. Strategic partnerships and a recent supply deal position RLG for broader growth in the country’s evolving consumer landscape.

Artrya Limited has secured FDA 510(k) clearance for its Salix Coronary Plaque module, enabling near real-time detection of high-risk coronary artery plaque and opening a lucrative U.S. market opportunity with a $950 reimbursement per scan.

Insignia Financial delivered a robust FY25 performance with an 18% rise in underlying net profit after tax, driven by higher funds under management and cost efficiencies, while announcing a $3.3 billion acquisition agreement with CC Capital Partners.